Rejeunesse Fine (1 x 1.1 ml)

Rejeunesse

Dermal filler

Cross-linked hyaluronic acid filler for fine to medium facial wrinkles and contouring

CE Marked Class III medical device according to information from brand and distributors (e.g., CE 1370 certification for Rejeunesse Fine with lidocaine).
Manufactured in South Korea by Newmedic Co., Ltd. under applicable medical device quality Management standards (e.g., ISO Based systems for dermal filler production).
Uses proprietary cross Linking and purification technology (such as UPHEC) to minimise residual BDDE and endotoxin levels and enhance safety.

CE Marked Class III medical device according to information from brand and distributors (e.g., CE 1370 certification for Rejeunesse Fine with lidocaine).
Manufactured in South Korea by Newmedic Co., Ltd. under applicable medical device quality Management standards (e.g., ISO Based systems for dermal filler production).
Uses proprietary cross Linking and purification technology (such as UPHEC) to minimise residual BDDE and endotoxin levels and enhance safety.
Non Animal Based hyaluronic acid filler produced in accordance with relevant international and regional regulations for injectable dermal fillers.

Description

Rejeunesse Fine is a sterile, pyrogen-free, 100% cross-linked hyaluronic acid dermal filler with lidocaine, designed for the correction of fine to medium facial wrinkles, superficial folds, and subtle contouring of the face and neck. The monophasic, viscoelastic gel contains non-animal hyaluronic acid at 24 mg/ml with 0.3% lidocaine to improve patient comfort during injection. It is injected into the superficial to mid dermis to smooth fine lines (such as periorbital, perioral, and forehead lines), refine lip contours, and gently restore lost volume while maintaining a natural look. The filler is intended for professional use only in adults (18+) who are not pregnant, breastfeeding, or allergic to its components.

Bnefits

Targets fine to medium wrinkles and superficial folds of the face and neck for a smoother, more youthful appearance.
Provides subtle volume restoration and contouring of facial features, including lips and facial outline.
Formulated with 24 mg/ml cross-linked, non-animal hyaluronic acid for long-lasting yet natural results.
Contains 0.3% lidocaine to reduce pain and discomfort during and immediately after injection.
High viscoelasticity and cohesivity support even distribution and stability in the superficial to mid dermis.
Non-animal origin HA and advanced purification technology (e.g., UPHEC) minimise residual BDDE and endotoxin levels.
Transparent, monophasic gel that is double sterilised for enhanced safety.
Clinical effect typically lasts around 8–12 months, depending on area treated, technique, and patient factors.

Indications

Prevention and correction of superficial wrinkles in the periorbital region (crow’s feet).
Treatment of fine to medium facial wrinkles and nasolabial folds.
Correction of forehead and glabellar (frown) lines, where appropriate.
Perioral line softening and lip contour correction.
Subtle lip volume enhancement in suitable patients.
Modelling and gentle contouring of the face and neck in superficial to mid dermal layers.
General improvement of skin smoothness and fine-line reduction in indicated facial areas.